Price alert —
Sign in to get a one-time email the moment SOLV crosses your price. Free accounts included.
Sign in / create a free accountPrice chart
Loading…
Latest bar · SOLV
Momentum reads · latest daily barGreen means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.
Financial overlay · last 12 quarters
The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.
| Quarter | Revenue | Net income | Op income | FCF | Net margin | Op margin |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2.0B | $0.0B | $0.1B | $-0.3B | 0.6% | 3.9% |
| 2025-12-31 | $2.0B | $0.1B | $0.1B | $0.0B | 3.2% | 4.7% |
| 2025-09-30 | $2.1B | $1.3B | $0.2B | $-0.0B | 60.4% | 8.2% |
| 2025-06-30 | $2.2B | $0.1B | $0.2B | $0.1B | 4.2% | 9.9% |
| 2025-03-31 | $2.1B | $0.1B | $0.2B | $-0.1B | 6.6% | 7.3% |
Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.
Compare SOLV vs peers
Line SOLV up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.
Add tickers to compare with SOLV
~30 metrics across Snapshot, OdysseyHQ zone, Valuation, Growth, Quality, Technicals, Sentiment, and Risk — with a weighted score and a one-line read on each.
Earnings replay · last 9 reports
How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.
| Date | EPS actual | EPS est | Surprise | Next-day |
|---|---|---|---|---|
| 2026-05-05 | 1.48 | 1.35 | +9.3% | +2.8% |
| 2026-02-26 | 1.57 | 1.50 | +5.0% | -3.6% |
| 2025-11-06 | 1.50 | 1.43 | +4.7% | +7.9% |
| 2025-08-07 | 1.69 | 1.45 | +16.2% | +2.0% |
| 2025-05-08 | 1.34 | 1.22 | +9.7% | +5.4% |
| 2025-02-27 | 1.41 | 1.31 | +7.8% | -4.4% |
| 2024-11-07 | 1.64 | 1.39 | +17.7% | -3.5% |
| 2024-08-08 | 1.56 | 1.51 | +3.6% | +3.3% |
| 2024-05-09 | 2.08 | 1.75 | +19.2% | -1.7% |
Earnings markers are overlaid on the daily price chart above. Click a ▲ marker for that day's move.
Peer comparison · Healthcare
Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.
| Ticker ⇅ | Mkt cap ⇅ | P/E ⇅ | Fwd P/E ⇅ | P/S ⇅ | EV/EBITDA ⇅ | P/B ⇅ | Gross M ⇅ | Rev gr ⇅ | EPS gr ⇅ | FCF yld ⇅ |
|---|---|---|---|---|---|---|---|---|---|---|
| SOLV ★ | $14B | 10.0 | 11.5 | 1.7 | 16.7 | 2.8 | 53.7% | -3.0% | -91.0% | 2.68% |
| LLY | $1,051B | 41.8 | 26.3 | 14.6 | 30.1 | 33.8 | 82.8% | 55.5% | 169.9% | 0.87% |
| UNH | $387B | 32.1 | 19.2 | 0.9 | 17.7 | 4.0 | 19.5% | 0.4% | 61.5% | 5.88% |
| JNJ | $609B | 29.3 | 19.7 | 6.2 | 18.4 | 7.5 | 68.1% | 6.6% | -1.0% | — |
| MRK | $315B | 36.0 | 13.2 | 4.8 | 12.1 | 6.9 | 76.7% | 4.9% | — | 4.46% |
| ABBV | $450B | 124.8 | 15.6 | 7.2 | 17.2 | -67.6 | 72.0% | 12.4% | -46.2% | 4.63% |
| PFE | $143B | 19.1 | 8.8 | 2.3 | 7.6 | 1.6 | 74.8% | 5.4% | -10.1% | 8.67% |
| TMO | $198B | 29.2 | 19.5 | 4.4 | 21.1 | 3.8 | 40.9% | 6.2% | 11.3% | 2.79% |
Auto-seeded from sector. Click any ticker to switch.
Ownership
Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.
Top institutional holders
Top-10 concentration: 43.68%
| Holder | Shares | % out |
|---|---|---|
| Independent Franchise Partners, LLP | 15,733,495 | 9.09% |
| Blackrock Inc. | 10,478,972 | 6.05% |
| Vanguard Capital Management LLC | 9,601,949 | 5.54% |
| Trian Fund Management, LP | 8,236,753 | 4.76% |
| State Street Corporation | 6,407,480 | 3.70% |
| Vanguard Portfolio Management LLC | 6,390,364 | 3.69% |
| Davis Selected Advisers | 6,330,325 | 3.66% |
| Geode Capital Management, LLC | 4,752,260 | 2.74% |
| Boston Partners | 3,914,091 | 2.26% |
| Invesco Ltd. | 3,789,883 | 2.19% |
Insider activity · 90d
11 buys / 0 sells · ratio 11.0 · Finnhub
- Edwards Shirley Ann BUY 3,300
- Mily Elizabeth BUY 3,300
- Wilson Darryl L. BUY 3,300
- DeVore Susan D. BUY 3,300
- ALBAN CARLOS BUY 3,300
- Wendell Amy McBride BUY 3,300
- Harris Bernard A Jr BUY 3,300
- EISENBERG GLENN A BUY 3,300
- WEILAND JOHN H BUY 3,300
- MAY KAREN J BUY 3,300
Analyst estimates
FinnhubWhat Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.
SEC filings
The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.
| Form | Filed | Description | Action |
|---|---|---|---|
| 8-K | 2026-06-05 | 8-K | view · |
| 8-K | 2026-05-27 | 8-K | view · |
| 8-K | 2026-05-20 | 8-K | view · |
| 4 | 2026-05-18 | FORM 4 | view · |
| 4 | 2026-05-18 | FORM 4 | view · |
| 4 | 2026-05-18 | FORM 4 | view · |
| 4 | 2026-05-18 | FORM 4 | view · |
| 4 | 2026-05-18 | FORM 4 | view · |
| 4 | 2026-05-18 | FORM 4 | view · |
| 4 | 2026-05-18 | FORM 4 | view · |
| 4 | 2026-05-18 | FORM 4 | view · |
| 4 | 2026-05-18 | FORM 4 | view · |
| 4 | 2026-05-18 | FORM 4 | view · |
| 4 | 2026-05-18 | FORM 4 | view · |
| 4 | 2026-05-15 | FORM 4 | view · |
| 4 | 2026-05-15 | FORM 4 | view · |
| 4 | 2026-05-15 | FORM 4 | view · |
| 4 | 2026-05-15 | FORM 4 | view · |
| 4 | 2026-05-15 | FORM 4 | view · |
| 4 | 2026-05-15 | FORM 4 | view · |
| 4 | 2026-05-15 | FORM 4 | view · |
| 10-Q | 2026-05-05 | 10-Q | view · |
| 8-K | 2026-05-05 | 8-K | view · |
| 4 | 2026-05-01 | FORM 4 | view · |
| 4 | 2026-05-01 | FORM 4 | view · |
| 4 | 2026-05-01 | FORM 4 | view · |
| 4 | 2026-05-01 | FORM 4 | view · |
| 4 | 2026-05-01 | FORM 4 | view · |
| 4 | 2026-05-01 | FORM 4 | view · |
| 4 | 2026-05-01 | FORM 4 | view · |
| 4 | 2026-05-01 | FORM 4 | view · |
| 4 | 2026-05-01 | FORM 4 | view · |
| 4 | 2026-05-01 | FORM 4 | view · |
| 4 | 2026-05-01 | FORM 4 | view · |
| 4 | 2026-03-30 | FORM 4 | view · |
| 4 | 2026-03-30 | FORM 4 | view · |
| 4 | 2026-03-30 | FORM 4 | view · |
| 4 | 2026-03-30 | FORM 4 | view · |
| 4 | 2026-03-30 | FORM 4 | view · |
| 4 | 2026-03-30 | FORM 4 | view · |
| 4 | 2026-03-30 | FORM 4 | view · |
| 4 | 2026-03-30 | FORM 4 | view · |
| 4 | 2026-03-30 | FORM 4 | view · |
| 4 | 2026-03-30 | FORM 4 | view · |
| 4 | 2026-03-30 | FORM 4 | view · |
| 4 | 2026-03-30 | FORM 4 | view · |
| DEF 14A | 2026-03-27 | DEF 14A | view · |
| 8-K | 2026-03-24 | 8-K | view · |
| 4 | 2026-03-11 | FORM 4 | view · |
| 4 | 2026-03-09 | FORM 4 | view · |
| 4 | 2026-03-09 | FORM 4 | view · |
| 4 | 2026-03-09 | FORM 4 | view · |
| 4 | 2026-03-09 | FORM 4 | view · |
| 4 | 2026-03-09 | FORM 4 | view · |
| 4 | 2026-03-09 | FORM 4 | view · |
| 4 | 2026-03-09 | FORM 4 | view · |
| 10-K | 2026-02-27 | 10-K | view · |
| 8-K | 2026-02-26 | 8-K | view · |
| 4 | 2026-02-03 | FORM 4 | view · |
| 4 | 2026-01-05 | FORM 4 | view · |
About SOLV
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The…
Options picks · SOLV
ITM + OTM ideas from the latest scanLoading…
Congress trades · SOLV
STOCK Act disclosuresLoading…
SEC filings & insiders · SOLV
EDGAR · liveLoading…
Holders · SOLV
Institutions & insider activityLoading…